UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cardiovascular research, ISSN 0008-6363, 10/2017, Volume 113, Issue 12, pp. E42 - E42
Journal Article
Nature communications, ISSN 2041-1723, 05/2019, Volume 10, Issue 1, pp. 2087 - 2087
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Recombinant Fusion Proteins - immunology | Immunotherapy, Adoptive - methods | Antigens, Neoplasm - immunology | Humans | Treatment Outcome | Receptors, Artificial - immunology | Receptors, Artificial - genetics | Xenograft Model Antitumor Assays | Neoplasms - therapy | Animals | Single-Chain Antibodies - genetics | Neoplasms - immunology | Cell Line, Tumor | Protein Domains | Recombinant Fusion Proteins - genetics | Female | Mice, Inbred NOD | Receptors, Antigen, T-Cell - immunology | T-Lymphocytes - immunology | Mice | Receptors, Antigen, T-Cell - genetics | Primary Cell Culture | Single-Chain Antibodies - immunology | Antigens, CD19 - immunology | Antigens | CD19 antigen | Surface antigens | Tumor cells | Xenotransplantation | T cell receptors | Lymphocytes T | Cell fusion | Anticancer properties | T-cell receptor | Chimeric antigen receptors | Receptors | Antitumor agents | Lymphocytes B | Lymphocytes | Antigen (tumor-associated) | Xenografts | Histocompatibility antigen HLA | Solid tumors | Tumors | Index Medicus
Journal Article
Experimental cell research, ISSN 0014-4827, 2011, Volume 317, Issue 9, pp. 1255 - 1260
Antibody | Bispecific | BiTE | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Antibodies, Bispecific - therapeutic use | Immunomodulation | Leukemia, Lymphoid - therapy | Humans | Lymphoma, B-Cell - therapy | Lymphoma, B-Cell - immunology | T-Lymphocytes - immunology | Clinical Trials as Topic | Antibodies, Bispecific - immunology | Leukemia, Lymphoid - immunology | Viral antibodies | Care and treatment | Leukemia | Antibodies | Non-Hodgkin's lymphomas | T cells | Health aspects | Cancer | Immunotherapy | Cells | CD19 antigen | Tumor cells | Bites | Clinical trials | Cytotoxicity | CD3 antigen | Lymphocytes T | Lymphatic leukemia | Non-Hodgkin's lymphoma | Side effects | Lymphocytes B | Remission | Bispecific antibodies | Index Medicus
Journal Article
2000, ISBN 0126366705, 591
eBook
Cancer research (Chicago, Ill.), ISSN 0008-5472, 06/2009, Volume 69, Issue 12, pp. 4941 - 4944
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Antibodies, Bispecific - therapeutic use | T-Lymphocytes - immunology | Neoplasms - therapy | Antibodies, Bispecific - immunology | Humans | Index Medicus
Journal Article
Current opinion in chemical biology, ISSN 1367-5931, 06/2013, Volume 17, Issue 3, pp. 385 - 392
Biochemistry & Molecular Biology | Biophysics | Life Sciences & Biomedicine | Science & Technology | Antibodies, Bispecific - therapeutic use | Animals | Neoplasms - immunology | Humans | T-Lymphocytes - immunology | Antibodies, Bispecific - immunology | Neoplasms - drug therapy | Viral antibodies | Antibodies | T cells | Immunotherapy | Tumors | Index Medicus
Journal Article
Pharmacology & therapeutics (Oxford), ISSN 0163-7258, 12/2012, Volume 136, Issue 3, pp. 334 - 342
Bispecific antibody | Lymphoma | Leukemia | BiTE | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antibodies, Bispecific - therapeutic use | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Animals | Lymphoma, Large B-Cell, Diffuse - drug therapy | Antibodies, Bispecific - administration & dosage | Humans | Lymphoma, Mantle-Cell - drug therapy | Antibodies, Bispecific - chemistry | Clinical Trials as Topic | MHC antibodies | Immunoglobulin G | Monoclonal antibodies | Transplantation | Non-Hodgkin's lymphomas | Hematopoietic stem cells | Index Medicus
Journal Article
8.
Clinical experience with gene therapy and bispecific antibodies for T cell-based therapy of cancer
Current pharmaceutical biotechnology, ISSN 1389-2010, 06/2012, Volume 13, Issue 8, pp. 1399 - 1408
Single-chain antibody | Catumaxomab | CD3 | T cell receptor | Chimeric antigen receptor | T-body | Tumor-associated antigen | Blinatumomab | Cancer therapy | T cell | Bispecific antibody | Zeta chain | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Bispecific - therapeutic use | Neoplasms - therapy | Animals | Recombinant Proteins - immunology | Neoplasms - immunology | Humans | Receptors, Antigen, T-Cell - immunology | T-Lymphocytes - immunology | Receptors, Antigen, T-Cell - genetics | Recombinant Proteins - genetics | Tumor cells | Adjuvants | Cytotoxicity | Data processing | Lymphocytes T | Vaccines | T-cell receptor | Reviews | Fusion protein | Gene therapy | Bispecific antibodies | Cancer | Pharmaceuticals
Journal Article
Cancer research (Chicago, Ill.), ISSN 0008-5472, 07/2009, Volume 69, Issue 14, pp. 5627 - 5629
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Tumors | Neoplasms - metabolism | Cell Adhesion Molecules - physiology | Signal Transduction | Humans | Stem Cells - metabolism | Cell Adhesion Molecules - metabolism | beta Catenin - metabolism | Epithelial Cell Adhesion Molecule | Animals | Models, Biological | Antigens, Neoplasm - physiology | Antigens, Neoplasm - metabolism | Protein Binding | Stem Cells - physiology | Neoplasms - physiopathology | Index Medicus
Journal Article
Nature reviews. Cancer, ISSN 1474-175X, 02/2009, Volume 9, Issue 2, pp. 143 - 143
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - metabolism | Epithelial Cells - metabolism | Neoplastic Stem Cells - metabolism | Cell Adhesion Molecules - metabolism | Humans | Control | Research | Health aspects | Stem cells | Cell adhesion molecules | Tumors | Index Medicus
Journal Article
Nature cell biology, ISSN 1465-7392, 2009, Volume 11, Issue 2, pp. 162 - 171
Life Sciences & Biomedicine | Science & Technology | Cell Biology | ADAM17 Protein | NIH 3T3 Cells | Cell Adhesion Molecules - genetics | Colonic Neoplasms - genetics | Cell Proliferation | Active Transport, Cell Nucleus - physiology | Homeodomain Proteins - metabolism | Humans | Lymphoid Enhancer-Binding Factor 1 - genetics | Male | Presenilin-2 - metabolism | Cell Membrane - genetics | Colonic Neoplasms - metabolism | Epithelial Cell Adhesion Molecule | Cell Nucleus - metabolism | Cell Transformation, Neoplastic - genetics | Muscle Proteins - metabolism | Antigens, Neoplasm - metabolism | Cell Membrane - metabolism | Protein Structure, Tertiary | Antigens, Neoplasm - genetics | Transcription Factors - genetics | Cell Adhesion Molecules - metabolism | Cell Transformation, Neoplastic - metabolism | Lymphoid Enhancer-Binding Factor 1 - metabolism | beta Catenin - metabolism | Homeodomain Proteins - genetics | beta Catenin - genetics | Muscle Proteins - genetics | Transcription Factors - metabolism | ADAM Proteins - metabolism | Animals | Cell Nucleus - genetics | Mitosis - physiology | Carcinoma - genetics | LIM-Homeodomain Proteins | Signal Transduction - physiology | Mice | Carcinoma - metabolism | Tumor antigens | Physiological aspects | Genetic aspects | Research | Health aspects | Cell adhesion molecules | Membrane proteins | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 18, pp. 2493 - 2498
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Antibody Specificity | Immunotherapy - methods | Humans | Middle Aged | Antibodies, Bispecific - pharmacokinetics | Drug Resistance, Neoplasm | Male | Molecular Targeted Therapy | Drug Delivery Systems | Neoplasm, Residual | Young Adult | T-Lymphocytes, Cytotoxic - drug effects | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Agammaglobulinemia - chemically induced | T-Cell Antigen Receptor Specificity - immunology | Aged, 80 and over | T-Cell Antigen Receptor Specificity - drug effects | Adult | Female | B-Lymphocytes - pathology | Antigens, CD19 - immunology | T-Lymphocytes, Cytotoxic - immunology | Antigens, Neoplasm - immunology | Lymphocyte Activation | Kaplan-Meier Estimate | Combined Modality Therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Remission Induction | Antibodies, Bispecific - therapeutic use | Cell Lineage | Disease-Free Survival | Antibodies, Bispecific - adverse effects | B-Lymphocytes - immunology | Bone Marrow - pathology | CD3 Complex - immunology | Aged | Lymphopenia - chemically induced | Index Medicus
Journal Article
Cancer and metastasis reviews, ISSN 0167-7659, 09/2020, Volume 39, Issue 3, pp. 969 - 987
Life Sciences & Biomedicine | Oncology | Science & Technology | Medical colleges | Antigens | Epidermal growth factor | Proteolysis | Colorectal cancer | Stem cells | Metastasis | Cell proliferation | Wnt protein | Epidermal growth factor receptors | Mesenchyme | Tumor cells | Epithelial cells | Colorectal carcinoma | Intracellular signalling | Raf protein | E-cadherin | Cell adhesion molecules | Cell adhesion & migration | Metastases | CD44 antigen | Intracellular | Cell migration | Index Medicus | Carcinoma | EpCAM | Regulated intramembrane proteolysis | Non-Thematic Review | Epithelial-to-mesenchymal transition | Liquid biopsy
Journal Article